EUCAST News
Here you can find the latest news and updates from EUCAST.
Tigecycline rationale and guidance documents
Tigecycline rationale and guidance documentswere revised.[more]
General consultation on proposed revision of chloramphenicol breakpoints
In a public consultation, EUCAST is asking for views on the proposed revision to chloramphenicol breakpoints. The last date for comments is 11 September, 2022.[more]
Fosfomycin - revised MIC distributions and ECOFFs
Fosfomycin: as part of the consultation process new fosfomycin MIC data was submitted. The old and new data have been assessed and, where appropriate, new ECOFFs determined. The new MIC data and ECOFFs are available at the EUCAST...[more]
Selective susceptibility testing and reporting
EUCAST still receives comments from colleagues in clinical microbiology that when organisms are reported “I” (Susceptible, increased exposure”), clinical colleagues will favor agents for which the organism has been reported “S”...[more]
Consultation on Breakpoints for C. diphtheriae and C. ulcerans.
The EUCAST general consultation on Corynebacterium diphtheriae and C. ulcerans is open for comments 9 July - 11 September, 2022. Together with specialists in Paris and Munich, 200 isolates of each species were investigated...[more]
Publication from the AFST 2022
Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications. Thomas R. Rogers, Paul E. Verweij, Mariana Castanheira, Eric...[more]
Cefiderocol susceptibility testing
Warning issued concerning cefiderocol susceptibility testing: there is currently no commercially available functioning test for cefiderocol MIC determination. EUCAST has investigated those available and all have problems with...[more]
